REGENXBIO's (RGNX) CEO Ken Mills on Q3 2017 Results - Earnings Call Transcript

11/9/17

REGENXBIO Inc. (NASDAQ:RGNX)

Q3 2017 Earnings Conference Call

November 8, 2017 4:30 PM ET

Executives

Patrick Christmas – General Counsel

Ken Mills – President and Chief Executive Officer

Vit Vasista – Chief Financial Officer

Analysts

Gbolahan Amusa – Chardon

Bin Lu – Raymond James

Josh Schimmer – Evercore ISI

Ying Huang – Bank of America Merrill Lynch

Operator

Good day, ladies and gentlemen, and welcome to the REGENXBIO Third Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]

I would now like to turn the conference over to Patrick Christmas, General Counsel. You may begin.

READ FULL ARTICLE HERE

It's on us. Share your news here.

Submit your stories and articles to citybizlist today.

Baltimore Business Spotlight

Feature Your Business Here

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect